Principal Clinical Scientist

CSL Plasma Inc.; Maidenhead; Hybrid; GBP 70,000 - 100,000; Full time

Job summary

CSL Seqirus is seeking a Principal Clinical Scientist to lead clinical studies from protocol development to close-out, co-owning end-to-end execution with outsourced partners. The role is hybrid with 3 days onsite in Maidenhead, UK, and options in Melbourne or Zurich.

You will author protocols and clinical study reports, partner with clinical operations, and drive scientific interpretation of data to advance development programs.

Qualifications

• Demonstrated hands-on experience with clinical studies from protocol development through to close-out.
• Experience writing clinical study protocols and clinical study reports directly.
• Experience working within a full-outsource/CRO-dependent operating model.
• Collaborative, cross-functional working style, comfortable building relationships.

Responsibilities

• Take ownership of clinical studies end-to-end as the scientific and operational anchor with outsourced partners.
• Lead all scientific elements from protocol development through study execution to final reports.
• Write and/or take responsibility for study protocols, clinical study reports, and other core documents.
• Manage day-to-day CRO relationships under a full-outsource operating model alongside the clinical operations lead.
• Collaborate with cross-functional study teams to ensure quality and timely delivery and contribute to data interpretation.

Skills

Clinical studies

Study protocols

Clinical study reports

Outsource/CRO model

Cross-functional collaboration

Job description

**Principal Clinical Scientist***(Senior Clinical Scientist level also considered)***The Role**We're looking for a clinical scientist — someone who has been the scientific lead for clinical studies before, from protocol development to start-up (development of critical study documents) through to study execution, data analysis and interpretation and close-out with a clinical study report. Having prepared regulatory submissions of study results is a pre. You'll work in close partnership with the clinical operations team and CROs under the team's full-outsource operating model, managing that day-to-day relationship rather than delivering trial activity in-house. It's one of two newly approved roles, created ahead of anticipated demand rather than to backfill a departure, which means there's genuine room to help shape how the team works rather than simply joining an existing structure.*Hybrid based (3 days a week onsite) in Maidenhead (UK), Melbourne (Aus) or Zurich (CH)***Why It Matters**A clinical study is only as good as the people running it. A weak protocol, poorly managed start-up, or a fumbled relationship with the CRO delivering the trial can cost a program months — sometimes far more — and that delay sits between a therapy and the patients waiting on it. This role exists because CSL is adding capacity to get that execution right: someone who can lead all scientific needs of a study properly, and co-own the end to end alongside clinical operations, is what actually moves a clinical development plan forward. It's not a supporting or administrative function — it's the core that determines whether the science translates into a trial that runs cleanly and data that holds up.**What You'll Be Responsible For**You'll take ownership of clinical studies end-to-end, acting as the scientific and operational anchor between the program team and outsourced delivery partners.* Lead all scientific elements of clinical studies from protocol development through study execution to a final clinical study report* Write and/or take responsibility for study protocols, clinical study reports and other critical study documents* Manage, alongside the clinical operations lead, day-to-day working relationships with CROs under a full-outsource operating model* Collaborate closely with the cross-functional study teams — this is a collaborative role, not an isolated one one* Contribute to the scientific interpretation of clinical data and supporting documentation* Build working relationships across the wider team, including colleagues based in the US and Australia**Experience Required*** Demonstrated, hands-on experience with clinical studies (protocol development, execution, close-out) — not solely oversight or academic exposure* Experience writing clinical study protocols and clinical study reports directly* Experience working within a full-outsource / CRO-dependent operating model* A collaborative, cross-functional working style — comfortable building relationships rather than working independently## **About CSL Seqirus**CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.**Our Benefits**For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.**You Belong at CSL**At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging**Equal Opportunity Employer**CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.